Immune will hold a Satellite Symposium on February 20th, 2017 at the International Symposium on Acute Leukemias (ISAL) XVI in Munich, Germany.
The satellite symposium is entitled: “Reinforcing the Efficacy of Immunotherapy for the maintenance of remission in AML with Ceplene” and will take place on Monday February 20th, 2017 from 12:45 – 13:45 CET in Lecture Hall III/IV in the conference venue.
Prof. Dr. Wolfgang Hiddemann (Munich, Germany), ISAL XVI Conference Chair, will chair the session. Speakers are international key opinion leaders in the field of hematological diseases and acute myeloid leukemia: Prof. Jacob Rowe (Jerusalem, Israel), and Prof. Kristoffer Hellstrand (Gothenburg, Sweden).
For more information about the Acute Leukemia symposium, please click here.